No Detail Found!

Frequency of hepatitis B virus infection among patients with rheumatoid arthritis: a study from a tertiary care centre in Peshawar

Author(s)
Abdul Jabbar DHQ Hospital Timergara, Khyber Pakhtunkhwa, Pakistan
Salim Badshah DHQ Hospital Timergara, Khyber Pakhtunkhwa, Pakistan
Muhammad Abbas DHQ Hospital Timergara, Khyber Pakhtunkhwa, Pakistan
Ahmad Ali DHQ Hospital Timergara, Khyber Pakhtunkhwa, Pakistan
Numan Khan DHQ Hospital Timergara, Khyber Pakhtunkhwa, Pakistan
Naveedullah DHQ Hospital Timergara, Khyber Pakhtunkhwa, Pakistan
Abstract
Understanding the prevalence is essential for developing guidelines for screening and managing hepatis B virus in rheumatoid arthritis patients, particularly in setings like Peshawar, where the burden of both diseases is likely to be high and viral infectivity may rise because of immunosuppression induced by anti-rheumatoid therapy. Therefore, this study was conducted to determine the frequency of Hepatis B virus (HBV) infection among patients with rheumatoid arthritis presenting at a tertiary care hospital in Peshawar. Methods: A cross-sectional study was conducted on 231 patients diagnosed with RA. Diagnosis was confirmed using clinical assessment and laboratory investigations, including rheumatoid factor and anti-cyclic citrullinated peptide. All laboratory tests were performed in a single hospital laboratory under the supervision of a senior pathologist. HBV infection was confirmed using a third-generation enzymelinked immunosorbent assay for hepatis B surface antigen with a cut-of value of 2.0. An independent t-test was applied, keeping p < 0.05 as statistically significant. Results: The age range of patients was 18-60 years, with 43% males and 57% females. Use of disease-modifying antirheumatic drugs was reported by 58% patients while steroid alone was used by 66% patients. HBV testing revealed that only 4% patients had positive and active hepatis B virus infection. No statistical significance (p > 0.05) was observed between HBV infection and age, gender, or type of treatment. Conclusion: The frequency of rheumatoid arthritis patients infected with Hepatis B was very low in the population from Peshawar. However, there is a need to screen hepatis B virus in all patients undergoing anti-arthritic therapy for improving early diagnosis and management in such cases.
Publication Details
Page(s) 28-32
Published Journal: Biomedica, Volume: 41, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
therapy, Rheumatoid Arthritis, immune-suppression, Hepatis B, DMARDs
References
Nguyen MH,Wong G,Gane E,Kao JH,Dusheiko G .2020 .Hepatitis B Virus: advances in prevention, diagnosis, and therapy. Clin Microbiol Rev, 33(2) : 19-19.
Hsu YC,Huang DQ,Nguyen MH .2023 .Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Rev Gastroenterol Hepatol, 20(8) : 524-37.
Revill PA,Chisari FV,Block JM,Dandri M,Gehring AJ,Guo H .2019 .A global scientific strategy to cure hepatitis B. Lancet Gastroenterol Hepatol, 1253(19) : 30151-7.
Weyand CM,Goronzy JJ .2021 .The immunology of rheumatoid arthritis. Nat Immunol, 22(1) : 10-8.
Alivernini S,Firestein GS,McInnes IB .2022 .The pathogenesis of rheumatoid arthritis. Immunity, 11(12) : 2255-70.
Scherer HU,Häupl T,Burmester GR .2019 .The etiology of rheumatoid arthritis. J Autoimmun, 110 : 102400.
Croia C,Bursi R,Sutera D,Petrelli F,Alunno A,Puxeddu I. .2019 .One year in review 2019: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol, 37(3) : 347-57.
Ridola L,Zullo A,Laganà B,Lorenzetti R,Migliore A,Pica R .2021 .Hepatitis B (HBV) reactivation in patients receiving biologic therapy for chronic inflammatory diseases in clinical practice. Ann dell'Istituto Super Sanita, 57(3) : 08-8.
Kuo MH,Tseng CW,Ko PH,Wang ST,Lu MC,Tung CH .2024 .HBV reactivation in HBsAg−/HBcAb+ rheumatoid arthritis patients receiving biologic/targeted synthetic DMARDs. Liver Int, 44(2) : 497-507.
Butola LK,Anjanker A,Vagga A,Kaple MN .2020 .Endogenous factor and pathophysiology of rheumatoid arthritis: an autoimmune disease from decades. Int J Cur Res Rev, 10(22) : 34-40.
Watanabe T,Fukae J,Fukaya S,Sawamukai N,Isobe M,Matsuhashi M .2019 .Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease-modifying anti rheumatic drugs. Int J Rheum Dis, 22(4) : 13401-185X.
Mehmood S,Raza H,Abid F,Saeed N,Rehman HM,Javed S .2020 .National prevalence rate of hepatitis B and C in Pakistan and its risk factors. J Public Health, 28 : 751-64.
Khan A,Ahmad I,Health J Public .2023 .Intra-familial spread of HBV among HbsAg positive parents and their children in a defined rural community of district Peshawar, Pakistan. , 13(1) : 11-4.
Hsu CS,Lang HC,Huang KY,Lin HH,Chen CL .2016 .Association of rheumatoid arthritis and hepatitis B infection: a nationwide nested case-control study from 1999 to 2009 in Taiwan. Medicine (Baltimore), 95(18) : .
Watanabe R,Ishii T,Kobayashi H,Asahina I,Takemori H,Izumiyama T .2014 .Prevalence of hepatitis B virus infection in patients with rheumatic diseases in Tohoku area: a retrospective multicenter survey. Tohoku J Exp Med, 233 : 129-33.
Shi Y,Zheng M. Hepatitis .2020 .B virus persistence and reactivation. BMJ, 370 : .
Tien YC,Yen HH,Chiu YM .2017 .Incidence and clinical characteristics of hepatitis B virus reactivation in HBsAg-negative/HBcAbpositive patients receiving rituximab for rheumatoid arthritis. Clin Exp Rheumatol, 35 : 831-6.
Alishiri GH,Ghorbani GA,Ahmad S. .2013 .Prevalence of hepatitis B infection in rheumatoid arthritis patients. Pakistan J Biol Sci, 747 : 747-50.
Yılmaz N,Karadağ Ö,Kimyon G,Yazıcı A,Yılmaz S,Kalyoncu U .2014 .Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis: a multi center countrywide study. Eur J Rheumatol, 1(2) : 51-4.
Golkocheva-Markova E,Ivanova S,Ivanova M,Gekova I,Stoilov N,Kostadinova A .2015 .Prevalence of the hepatitis B virus markers among patients with ankylosing spondylitis and rheumatoid arthritis. J BioSci Biotechnol, : .
Duan L,Yang C,Cai T,Li W. .2023 .Clinical effects of HBV infection on patients with rheumatoid arthritis and systemic lupus Erythematosus. Pak J Med Sci, 39(5) : 7232-50.
Lan TY,Lin YC,Tseng TC,Yang HC,Kao JH,Cheng CF .2023 .Risk of Hepatitis B Virus (HBV) reactivation in HBsAg-negative, antiHBc-negative patients receiving rituximab for autoimmune diseases in HBV endemic areas. Gut Liver, 17(2) : 288.
0

Citations

0

Downloads

138

Views